Journal News

From the journals: MCP

Ankita Arora
April 22, 2022

Uncovering a rare disease’s brain proteome. Standardizing immunopeptidome data sets. Analyzing Matrigel for organoids. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Uncovering a rare disease’s brain proteome

Astrocytes (green), seen here in a mouse, are star-shaped cells in the brain<br/>and spinal cord.
National Institute of Child Health and Human Development/NIH Flickr
Astrocytes (green), seen here in a mouse, are star-shaped cells in the brain and spinal cord.

Alexander disease, or AxD, is one in a group of an ultra-rare nervous disorders called leukodystrophies. In these disorders, sometimes called “white-matter diseases,” myelin — the white fatty insulating layer that surrounds the nerves and promotes the rapid transmission of nerve impulses — is destroyed. This hinders nerve impulses and nervous system functions. AxD also is characterized by abnormal protein aggregates called Rosenthal fibers within brain cells known as astrocytes. AxD is caused by gain-of-function mutations in the gene encoding glial fibrillary acidic protein, or GFAP.

To understand the disease at a molecular level, researchers use mice that have been altered genetically to mimic AxD symptoms. One such mouse contains a disease-causing heterozygous point mutation at R236H in mouse Gfap and a human transgenic GFAP, leading to increased levels of GFAP in astrocytes. In a recent study published in the journal Molecular & Cellular Proteomics, Michael R. Heaven of Vulcan Biosciences and a team from around the U.S. compared whole-brain proteomes of altered and unaltered mice and identified pathways and proteins that are differentially expressed in the AxD mice.

Using liquid chromatography with tandem mass spectrometry–based proteomics, the team found that two pathways, namely glutathione metabolism and the peroxisome proliferator-activated receptor, or PPAR, signaling pathway, are upregulated, suggesting a role in neuroprotection. They also noted that levels of UDP-galactose-ceramide galactosyltransferase, or Ugt8, a regulator of myelin membrane synthesis, were decreased and that mice that were altered genetically to remove Ugt8 shared phenotypic characteristics of the AxD mice. Lastly, a fatty acid binding protein that activates the NF-B inflammatory response and thereby decreases the neuroprotective effects of the PPAR pathway was upregulated in both AxD mice and human patients.

This study exemplifies the use of high-resolution mass spectrometry–based proteomics to investigate whole-brain tissue in animal disease models when it is not possible to obtain sufficient patient tissues.

Standardizing immunopeptidome data sets

Most cells cut their own proteins into fragments called immunopeptides and present these fragments to T cells — like evidence offered to a detective. The T cells determine if the evidence, the immunopeptides, are self or foreign and, if the latter, trigger an immune response to neutralize the threat. Cancer cells and infectious pathogens generate foreign immunopeptides that mark them for destruction and hence have great potential for highly specific therapeutic approaches. With the development of high-sensitivity mass spectrometry–based proteomics, scientists have discovered new cancer-specific antigens. However, standards to assess the quality of immunopeptidomic data generated by mass spec largely are falling behind the pace of discovery.

In a recent paper published in the journal Molecular & Cellular Proteomics, Kevin A. Kovalchik of CHU Sainte-Justine Research Center and a Canada-based team created the first user friendly quality control software tool, named MhcVizPipe, or MVP, that enables rapid and simultaneous assessment of large immunopeptidomic data sets. The authors showed that MVP, when compared to manual approaches, accelerates the analysis and data generation process about 22-fold on average. Thus, MVP serves as a great starting point for nonexperts to delve into immunopeptidomics and will foster greater accessibility and expansion of the field.

Matrigel — a necessary evil for organoids?

Researchers have been shifting recently toward growing and dividing cells in three-dimensional instead of two-dimensional cultures in petri dishes. These 3D cell cultures, called organoids, simulate microscopic and molecular features of original tissues. Hence, organoids are more clinically relevant and have tremendous therapeutic potential. Proteomic profiling of organoids could be valuable to test treatment regimens and find novel biomarkers.

Most organoids are grown in the solubilized basement membrane matrix Matrigel, which serves as a scaffold and provides mechanical properties and signaling cues for cell attachment and survival. However, Matrigel is complex and poorly defined, making it difficult to identify specific ingredients necessary for organoid function. Furthermore, thousands of identical peptides are shared between Matrigel and organoids, and insufficiently dissolved Matrigel could influence proteomic analysis of organoids.

In a recent article published in the journal Molecular & Cellular Proteomics, Man Wang, Huan Yu and colleagues at Peking University compared three Matrigel dissolving methods (cell recovery solution, dispase, and phosphate buffered saline–ethylenediaminetetraacetic acid buffer) and studied the effect of undissolved Matrigel proteins on proteomic profiles of organoids. They found that dispase digestion was the best method, with the highest peptide yield and highest incorporation ratio of stable isotopes. Further, 312 high-confidence Matrigel contaminants were identified, and they found that exclusion of the contaminants minimized Matrigel interference.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Ankita Arora

Ankita Arora is a postdoctoral research fellow at the University of Colorado Anschutz Medical Campus.

Related articles

From the journals: MCP
Courtney Chandler
From the journals: MCP
Nivedita Uday Hegdekar
From the journals: MCP
Courtney Chandler

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Zinc is a metal essential to life
News

Zinc is a metal essential to life

May 25, 2022

Scientists have discovered a protein that helps keep cells alive when zinc levels are low.

The mechanism of the monkeypox antiviral
News

The mechanism of the monkeypox antiviral

May 24, 2022

As monkeypox becomes an international concern, interest grows in tecovirimat; this smallpox drug targets a structural protein that helps wrap the virus in a second lipid bilayer.

Researchers investigate self-regulation of an enzyme with critical cellular functions
News

Researchers investigate self-regulation of an enzyme with critical cellular functions

May 24, 2022

They found that one mechanism of CK1 activity, and thus one mechanism of regulation, is the self-phosphorylation of a conserved amino acid residue in its catalytic domain.

What is monkeypox?
Science Communication

What is monkeypox?

May 23, 2022

A microbiologist explains what’s known about this smallpox cousin.

A simple method to determine phase preference of proteins on live cell membranes
Journal News

A simple method to determine phase preference of proteins on live cell membranes

May 22, 2022

“The phase preference of molecules used to be difficult and time-consuming to establish. This new method, detected by chance, provides results in at most 15 minutes on live cells,” Thorsten Wohland said.

Study of Alzheimer’s marker prompts warning about serine supplements
News

Study of Alzheimer’s marker prompts warning about serine supplements

May 20, 2022

They have been advertised to improve memory and cognitive function.